MiniMed Group, Inc. (MMED) stock
MMEDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 13/3050% below fair value
$17.78−0.87 (-4.66%)
Close on Nov 17, 2026Market cap $5.00BP/E –Yield –
MiniMed r&d expenses
Research and development expenses are spending on new products and technology.
MiniMed's R&D Expenses for the twelve months ending Apr 24, 2026 was $448.00M, up 2.8% year over year. For fiscal 2026 it was $448.00M, up 2.8% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 24, 2026 | $448.00M | +2.8% |
| FY2025 | Apr 25, 2025 | $436.00M | -0.2% |
| FY2024 | Apr 26, 2024 | $437.00M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | $115.00M | +7.5% |
| Q4 FY2026CQ1 2026 | Apr 24, 2026 | $99.00M | -11.6% |
| Q3 FY2026CQ4 2025 | Jan 23, 2026 | $114.00M | – |
| Q1 FY2026CQ2 2025 | Jul 25, 2025 | $125.00M | – |
| Q4 FY2025CQ1 2025 | Apr 25, 2025 | $107.00M | – |
| Q3 FY2025CQ4 2024 | Jan 24, 2025 | $112.00M | – |
See a number that looks wrong?